Scientists reveal prostate cancer’s multiple personalities
November 4th, 2010 - 2:34 pm ICT by ANIWashington, Nov 4 (ANI): A team of scientists has taken an important step toward a better understanding of prostate cancer by uncovering evidence that it is not one disease but rather several factors which can be measured and, in the future, destroyed by targeted therapy.
The research team led by of Dr. Mark A. Rubin, at Weill Cornell Medical College, identified secondary mutations that cause some types of prostate cancer cells to be lethal.
They believes that their discovery will lead to better tests for prostate cancer, sparing thousands of men from unnecessary biopsies, and leading to more specific and individualized therapy for prostate cancers that are likely to become deadly.
The current research expands on the team’s previous work with University of Michigan that reported the first evidence that gene fusions, hybrid genes formed from two previously separate genes, play a widespread role in prostate cancer.
This novel observation supports the view that aggressive cancers need to accumulate multiple mutations. Using discoveries made in this study, clinicians may be better able to diagnose and target potentially deadly tumors.
“In the future, these fusions, specific to certain types of prostate cancer, may help physicians prescribe tailored therapies for their patients. This is an important step toward providing specific therapies that target individual cancer variants, and our hope is these findings will help doctors diagnose a patient’s specific disease,” explained Rubin
This research has led Rubin and his colleagues to co-develop the diagnostics for a new test for prostate cancer.
“The new test being developed will identify cells that are seen only in people with prostate cancer, allowing us to know with great certainty who has prostate cancer. This will result in fewer unnecessary biopsies, which have potential side effects, including infections, bloody semen, and rectal bleeding,” he concluded.
The study results were published in online edition of the journal Genome Research. (ANI)
- Newly discovered gene fusion may improve prostate cancer diagnosis - Jul 24, 2009
- Full genetic blueprint of multiple prostate tumors unveiled - Feb 10, 2011
- New ultrasound technology can accurately spot prostate cancer tumours - Dec 09, 2010
- Gene fusion is the 'smoking gun' in the development of prostate cancer: Study - May 19, 2010
- Potential driver of some aggressive prostate cancers found - Apr 05, 2011
- Gene mutations help leukemia drug fight squamous cell lung cancer - Apr 04, 2011
- Change in PSA level poor predictor of prostate cancer - Feb 25, 2011
- Scientists discover potential new drug therapy for kidney diseases - Apr 27, 2011
- Dogs can 'sniff out' prostate cancer accurately from urine sample - Feb 08, 2011
- New protein drives prostate cancer cells to 'suicide' - Feb 01, 2011
- Compound to starve cancers of sugar-based building blocks found - Nov 19, 2010
- Measles virus is 'the latest weapon against cancer' - Jan 13, 2011
- Exercise improves survival in prostate cancer patients - Feb 02, 2012
- Simple test could save prostate cancer patients from surgery - Feb 09, 2011
- Drug for rare childhood cancer may help prevent prostate cancer spread - Apr 30, 2011
Tags: bloody semen, clinicians, cornell medical college, current research, dr mark, first evidence, hybrid genes, multiple personalities, mutations, new test, prostate cancer, prostate cancer cells, prostate cancers, several factors, study result, target, types of prostate cancer, unnecessary biopsies, weill cornell medical, weill cornell medical college